Glimepiride treatment and IGF-I in adolescents with type 1 diabetes: a prospective, randomized, double-blind, placebo-controlled study.
Wudy
Stefan A
SA
Högel
Josef
J
Dollinger
Barbara
B
Mullis
Primus
P
Heinze
Eberhard
E
D000293:Adolescent; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D010919:Placebos; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D018972:Insulin-Like Growth Factor Binding Protein 3; D010919:Placebos; D013453:Sulfonylurea Compounds; D007334:Insulin-Like Growth Factor I; C057619:glimepiride